Intelligence Platform
Patents
Browse 1,756 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 6855804
Covalently reactive transition state analogs and methods of use thereof
expired patentUS 6852685
Use of colostrinin, constituent peptides thereof, and analogs thereof to promote neuronal
expired patentUS 6849429
Viral pseudo-capsids including assembly agonists and antagonists
expired patentUS 6846809
PEI: DNA vector formulations for in vitro and in vivo gene delivery
expired patentUS 6846807
Colorectal neoplasia prophylaxis
expired patentUS 6844320
Treatment of preeclampsia, toxemia and preterm labor with combination of progestational ag
expired patentUS 6844004
Topical formulations of natamycin/pimaricin
expired patentUS 6830749
Recombinant P53 adenovirus methods and compositions
expired patentUS 6825186
Method and compositions for treating atheroma, tumors and other neoplastic tissue
expired patentUS 6821505
Immunoglobin-like domains with increased half lives
expired patentUS 6821750
ABCG8 vectors, host cells, and method of making
expired patentUS 6818213
Cancer treatment compositions comprising therapeutic conjugates that bind to aminophosphol
expired patentUS 6814970
Methods and compositions including a 13 kD B. burgdorferi protein
expired patentUS 6815416
Stimulation of cartilage growth with agonists of the non-proteolytically activated thrombi
expired patentUS 6808702
Treatment of disorders by implanting stem cells and/or progeny thereof into gastrointestin
expired patentUS 6806354
Methods and compositions for inducing autoimmunity in the treatment of cancers
expired patentUS 6806065
Rickettsia felis outer membrane protein
expired patentUS 6805858
Methods for the administration of adenovirus p53
expired patentUS 6797702
Methods and compositions comprising DNA damaging agents and P53
expired patentUS 6783760
Combined cancer treatment methods using therapeutic conjugates that bind to aminophospholi
expired patentUS 6764826
Inhibitors of C-reactive protein induced inflammation
expired patentUS 6756408
Methods and materials for protecting against myocardial cell damage related to coronary in
expired patentUS 6756062
Preparation of drug particles using evaporation precipitation into aqueous solutions
expired patentUS 6753417
UspA1 and UspA2 antigens of Moraxella catarrhalis
expired